Delivery Order SPE2DB22D2007-SPE2DB25FJ4AY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Diovan HCT 160-12.5 mg tablets (90-count) with a ceiling value of $17,047.43. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is due for completion by August 13, 2025. The award was executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Diovan HCT 160-25 mg tablets (90 count) with a ceiling value of $1,038.57. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is scheduled for completion by August 11, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a task...
- The Defense Logistics Agency awarded a delivery order valued at $20,575.76 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-12.5 mg tablets (90-count) under a firm fixed price arrangement. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and is classified as a non-set-aside competitive procurement. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Diovan HCT 320-12.5 mg tablets (90-count) with a firm fixed price ceiling value of $1,746.64. This non-set-aside, competitively awarded contract is scheduled for ultimate completion on July 22, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical...
- The Defense Logistics Agency awarded a delivery order valued at $97,006.28 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-25 mg tablets (90-count) under a firm fixed price contract. The award, issued on July 23, 2025, with completion by July 24, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,096.46 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Diovan HCT 320-12.5 mg tablets (90-count units). The contract represents a firm fixed price, non-set-aside procurement with an ultimate completion date of July 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Diovan HCT 80-12.5 mg tablets (90-count) valued at $8,201.10. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $5,570.45 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 320-25 mg tablets (90-count units) under a firm fixed price arrangement. The contract was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, and does not utilize a set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Diovan HCT 320-12.5 mg tablets (90-count) with a ceiling value of $3,437.75. This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,931.27 firm fixed-price delivery order is for the supply of Diovan HCT 160-12.5 mg tablets. The contract has an ultimate completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00. This prime contract,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4AYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,090.39 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Diovan HCT 80-12.5 mg tablets (90-count bottles). This competitive award, issued without set-aside designation, utilizes firm fixed pricing and is scheduled for completion by August 19, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through open competition and maintains an extensive portfolio of federal medical product deliveries across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/18/25 |